New Key Statistics Module, Z-Score and F-Score
OTCPK:CHGCY Key Ratios
Market Cap $ M | 50,611.89 |
Enterprise Value $ M | 45,709.05 |
P/E(ttm) | 24.46 |
PE Ratio without NRI | 24.46 |
Forward PE Ratio | 22.78 |
Price/Book | 4.86 |
Price/Sales | 7.71 |
Price/Free Cash Flow | 24.68 |
Price/Owner Earnings | 24.97 |
Payout Ratio % | 0.40 |
Revenue (TTM) $ M | 7,119.00 |
EPS (TTM) $ | 0.68 |
Beneish M-Score | -3.01 |
10-y EBITDA Growth Rate % | 25.20 |
5-y EBITDA Growth Rate % | 31.70 |
y-y EBITDA Growth Rate % | -0.10 |
EV-to-EBIT | 16.26 |
EV-to-EBITDA | 16.26 |
PEG | 0.77 |
Shares Outstanding M | 3,290.76 |
Net Margin (%) | 31.50 |
Operating Margin % | 42.54 |
Pre-tax Margin (%) | 42.86 |
Quick Ratio | 4.37 |
Current Ratio | 5.53 |
ROA % (ttm) | 17.64 |
ROE % (ttm) | 21.05 |
ROIC % (ttm) | 31.38 |
Dividend Yield % | 1.75 |
Altman Z-Score | 20.73 |
CHGCY Number of Guru Trades
CHGCY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CHGCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CHGCY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chugai Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:CHGCY
Total 0- 1